Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 29% ± 12% | |
| oligodendrocyte precursor cell | 6 studies | 26% ± 11% | |
| epithelial cell | 6 studies | 32% ± 10% | |
| oligodendrocyte | 6 studies | 23% ± 6% | |
| GABAergic neuron | 5 studies | 31% ± 9% | |
| astrocyte | 5 studies | 25% ± 7% | |
| fibroblast | 4 studies | 22% ± 5% | |
| type I pneumocyte | 4 studies | 18% ± 3% | |
| glutamatergic neuron | 4 studies | 37% ± 11% | |
| interneuron | 4 studies | 30% ± 17% | |
| microglial cell | 3 studies | 20% ± 1% | |
| ciliated cell | 3 studies | 23% ± 4% | |
| abnormal cell | 3 studies | 21% ± 5% | |
| basal cell | 3 studies | 27% ± 8% | |
| goblet cell | 3 studies | 30% ± 15% | |
| neuron | 3 studies | 32% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 30% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1672.57 | 1445 / 1445 | 100% | 22.59 | 183 / 183 |
| lung | 100% | 1720.88 | 578 / 578 | 100% | 22.99 | 1155 / 1155 |
| prostate | 100% | 2040.49 | 245 / 245 | 100% | 22.19 | 502 / 502 |
| breast | 100% | 1666.11 | 459 / 459 | 100% | 26.81 | 1116 / 1118 |
| intestine | 100% | 1929.66 | 966 / 966 | 100% | 22.13 | 526 / 527 |
| bladder | 100% | 1923.05 | 21 / 21 | 100% | 20.42 | 503 / 504 |
| kidney | 100% | 1416.10 | 89 / 89 | 100% | 22.66 | 899 / 901 |
| brain | 100% | 1334.51 | 2637 / 2642 | 100% | 33.66 | 704 / 705 |
| stomach | 100% | 1525.86 | 359 / 359 | 100% | 21.38 | 285 / 286 |
| thymus | 100% | 2129.39 | 653 / 653 | 100% | 27.41 | 602 / 605 |
| ovary | 100% | 1938.08 | 180 / 180 | 99% | 14.01 | 426 / 430 |
| pancreas | 100% | 1463.39 | 328 / 328 | 99% | 22.23 | 176 / 178 |
| uterus | 100% | 2011.52 | 170 / 170 | 99% | 19.62 | 453 / 459 |
| adrenal gland | 100% | 1621.92 | 258 / 258 | 98% | 16.89 | 225 / 230 |
| liver | 100% | 1237.64 | 226 / 226 | 95% | 12.16 | 386 / 406 |
| skin | 100% | 2410.81 | 1809 / 1809 | 94% | 17.97 | 446 / 472 |
| adipose | 100% | 1676.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1788.61 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 19.48 | 29 / 29 |
| spleen | 100% | 1450.71 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.03 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.63 | 1 / 1 |
| muscle | 100% | 963.46 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 887.67 | 826 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 89% | 1343.46 | 827 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 8.54 | 66 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | RSPRY1 |
| Protein name | RING finger and SPRY domain-containing protein 1 Ring finger and SPRY domain containing 1 |
| Synonyms | KIAA1972 UNQ328/PRO444 |
| Description | |
| Accessions | ENST00000568505.6 Q96DX4 H3BQQ7 ENST00000562439.5 ENST00000564435.5 H3BQG6 ENST00000394420.9 [Q96DX4-1] H3BPL2 H3BSC7 ENST00000562959.1 ENST00000561641.1 ENST00000537866.5 [Q96DX4-1] |